niamhcurran
NovaSignal launches the NovaGuide 2
NovaSignal has announced the launch of the NovaGuide 2 platform, which provides clinical teams with real-time information about cerebral blood flow to guide diagnosis...
FDA approves application for phase I study of MLC1501 programme in...
Moleac has announced the approval of the US Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic...
NVQI-QOD and SVIN form new alliance
The Society of Neurointerventional Surgery (SNIS) and NeuroPoint Alliance (NPA) have announced an alliance between the Society of Vascular and Interventional Neurology (SVIN) and...
Greater outreach needed for women and minority pain patients
During a presentation at the North American Neuromodulation Society (NANS) virtual meeting (15–16 January) entitled “Outcomes and Access to Neuromodulation for Women and Underrepresented...
New thrombectomy device offers promising results
In a late-breaking presentation given on the final day of the International Stroke Conference (ISC) virtual meeting (17–19 March), researchers presented a “promising” new...
NeuroNews issue 41 – US
Highlights:
Coverage of the International Stroke Conference (ISC; 17–19 March, virtual), including results from the TIGER trial
The reasons women are still underrepresented in...
NeuroNews issue 41 – EU
Highlights:
Coverage of the International Stroke Conference (ISC; 17–19 March, virtual), including results from the TIGER trial
The reasons women are still underrepresented in...
Oxford Endovascular raises US$10 million to develop brain haemorrhage device
Oxford Endovascular has announced that it has raised US$10 million in a series A funding round for the development of its OxiFlow micro stent,...
Vysioneer receives FDA clearance for tumour auto-contouring solution
Vysioneer, a provider of artificial intelligence (AI) for cancer care, has received clearance from the US Food and Drug Administration (FDA) for VBrain. In...
Research finds a decline in global stroke care during the pandemic
A study published in the journal Neurology concludes that despite the reported stroke-related complications of COVID-19, there has been a global decline in the volume of stroke...
First-in-human study demonstrates use of high-bandwidth wireless brain-computer interface
Results of the BrainGate clinical trial, published in the journal IEEE Transactions on Biomedical Engineering, detail the first-in-human use of a new wireless brain-computer interface (BCI) in patients with tetraplegia....
NeuroNews’ top 10 most popular stories for March 2021
Our top stories from March 2021, including: International Stroke Conference (ISC; 17–19 March, virtual) coverage, mechanical thrombectomy for posterior circulation distal, medium vessel occlusion...
Irras announces collaboration with Aarhus University Hospital
Irras has announced a strategic collaboration with the neurosurgical team at Aarhus University Hospital in Aarhus, Denmark, to evaluate the use of the Irraflow...
Repetitive TMS demonstrates ability to reduce suicidal thoughts and behaviours
The use of transcranial magnetic stimulation (TMS) has a modest yet promising history in suicide reduction, according to the authors of a study published...
Inbrain Neuroelectronics secures funding for AI-powered graphene-brain interface
Inbrain Neuroelectronics has announced that it has raised US$18.8 million in series A funding for its artificial intelligence (AI)-powered, graphene neuromodulation technology.
According to a...
Tigertriever receives FDA clearance following ISC presentation
Rapid Medical has announced the US Food and Drug Administration (FDA) clearance of its Tigertriever revascularisation device for use in the treatment of ischaemic stroke. According...
Non-invasive PoNS device receives marketing authorisation from FDA
Helius Medical Technologies has announced that its Portable Neuromodulation Stimulator (PoNS) device, for multiple sclerosis sufferers, has received marketing authorisation from the US Food and...
Ischaemic stroke and TIA risk in COVID-19 patients lower than previously...
The elevated risk of ischaemic stroke and transient ischaemic attack TIA in hospitalised COVID-19 patients may be lower than previously reported—although it is still...
Despite more stroke patients receiving EVT, racial disparities persist
A late-breaking science presentation at the International Stroke Conference (ISC) 2021 (17–19 March, online) reports that while the use of mechanical clot removal or...
Viz.ai announces new data on AI stroke platform
Viz.ai presented new data supporting the use of its technology to coordinate care for acute ischaemic stroke, haemorrhagic stroke, and clinical trial recruitment at...
No significant difference between IVT plus EVT compared with EVT alone
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17–19 March, virtual) reports results from the MR CLEAN-NO IV trial, which is...
Overestimation of ischaemic core on computed tomography perfusion
Álvaro García-Tornel Garcia-Camba discusses his recent publication in Stroke, which aimed at evaluating the influence of time and collateral status on ischaemic core overestimation....
Medtronic receives CE mark for SenSight directional lead system for DBS...
Medtronic has announced that it has received CE mark for the SenSight directional lead system for deep brain stimulation (DBS) therapy as treatment of...
Sevaro Health launches its telestroke platform Sevaro OneCall
Sevaro Health has announced the launch of Sevaro OneCall, a proprietary platform which, according to a company press release, enables immediate access to neurologists...
Mobile stroke units may “result in lower rates of disability”
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17 –19 March, online) has presented evidence that patients who received care from...
Immediate angiography may reduce stroke treatment time
A late-breaking abstract presented at the International Stroke Conference (ISC) 2021 (17–19 March, online) reports that immediate angiography, rather than the standard computed tomography (CT scan), reduced...
MagVenture introduces MagVenture Flow Arm use in non-invasive brain stimulation
MagVenture has introduced the MagVenture Flow Arm — a patent-pending, clinical positioning system to optimise the delivery of MagVenture's FDA cleared protocols for non-invasive...
BrainQ trial results show a potential reduction in disability after stroke
BrainQ, an Israeli start-up with an artificial intelligence- (AI) powered therapeutic platform, has announced the results from a randomised controlled trial (RCT), showing 77%...
Women in neurosurgery: Why is the field still male-dominated?
Factors including representation, a lack of mentoring, and discrimination have been among the issues cited by female neurosurgeons as contributing to gender disparity in the field....
Study finds Neuroprotectant delivered to the brain in nanoparticles may improve...
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that when NA1, a neuroprotectant, was...
Differences found in stroke severity and post-stroke care among Black and...
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that Black and Hispanic women aged...
Even short delays in the ER reduce the lifespan of stroke...
Research to be presented at the International Stroke Conference (ISC) 2021 meeting (17-19 March, virtual) has found that for every 10-minute delay between arrival...
Research finds redlined neighbourhoods had higher rates of stroke
Research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) reports that neighbourhoods affected by the historic housing policies...
Cascade17 dynamic non-occlusive remodelling net launched to European market
Perflow Medical has launched its Cascade17 non-occlusive remodelling net to the European market. According to a company press release the device has already received...
Completion of first pilot for the Rise&Walk InClinic robotic technology announced
Healing Innovations has announced the completion of the first pilot for its new Rise&Walk InClinic technology at Shepherd Center in Atlanta, USA. The pilot...
Abbott announces NeuroSphere Virtual Clinic
Abbott has announced the US launch of its NeuroSphere Virtual Clinical, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings...
Study finds less than 2% of COVID-19 patients suffered ischaemic stroke
A study published in Stroke reviewing nearly 28,000 emergency department records across 54 healthcare facilities has shown that less than 2% of patients diagnosed with COVID-19 suffered...
NeuroNews’ top 10 most popular stories for February 2021
Our top stories from February 2021, including: The effectiveness of mobile stroke units, evidence for a new transient ischaemic attack (TIA) scoring system, endovascular...
Aesculap Aeos receives FDA approval for use of digital infrared fluorescence
Aesculap has announced its receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for DIR800 3D digital infrared fluorescence for use...
Nimbus RF multitined expandable electrode receives US patent
Stratus Medical has announced that it has been granted a patent for its Nimbus radiofrequency (RF) multitined expandable electrode from the US Patent and Trademark Office....
Study finds mechanical thrombectomy for posterior circulation DMVO safe, and technically...
A study recently published in The Journal of the American Medical Association (JAMA) has found that mechanical thrombectomy for posterior circulation distal, medium vessel occlusion...
ReFlow system mini receives FDA breakthrough device designation
Anuncia has announced that it has received US Food and Drug Administration (FDA) breakthrough device designation for its ReFlow system mini, intended for the treatment of cerebral spinal...
First neuro product approved in Forfait Innovation
Evasc Neurovascular has announced its successful application to France’s Ministry of Health (Haute Autorité de la Santé, HAS) Forfait Innovation (FI) programme for the...
New research may help prevent recurrent strokes
Results from a phase II clinical trial conducted by vascular neurologists at Cedar-Sinai, Los Angeles, USA, show there is potential to reduce the rate...
Complete reperfusion may not offer better outcomes than near-complete reperfusion
Ching-Jen Chen discusses his recent publication in the BMJ entitled, “Is a picture-perfect thrombectomy necessary in acute ischaemic stroke?”
Whether imaging findings translate into outcomes...
Newronika announces CE mark for AlphaDBS system
Newronika has announced the CE mark approval for its AlphaDBS system to treat Parkinson’s disease. According to a company press release, Newronika is a spin-off of the world-class neurological research centre Policlinico of Milan...
Icometrix announces ischaemic stroke solution
In a press release, icometrix announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. According to the company, this announcement follows clearance from the US...
BrainStorm’s NurOwn does not have enough clinical data according to FDA
BrainStorm Cell Therapeutics announced it recently met with senior leadership from the US Food and Drug Administration (FDA) and received feedback on a high-level data summary...
Timo Krings
“The most profound and scaring changes I felt are the impact of increased levels of anxiety and stress on the team,” comments Timo Krings...
Stryker partners with Brainomix for AI stroke software
Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.
According to a press release...
German study shows use of mobile stroke units improves clinical outcomes
In a study published in The Journal of the American Medical Association (JAMA), researchers have found that stroke patients in Berlin for whom STEMOs...
phenox GmbH opens UK office
phenox GmbH has announced the opening of a permanent UK office in the south of Birmingham, UK. The company states in a press release...
The post-stroke brain’s ability to recover and rewire itself peaks at...
A study published in Neurorehabilitation and Neural Repair finds that the capacity of the human brain to recover and rewire itself peaks around two...
Cerus Endovascular receives FDA breakthrough device designation for Contour Neurovascular System
Cerus Endovascular has received breakthrough device designation from the US Food and Drug Administration (FDA) for its Contour Neurovascular System.
The Contour Neurovascular System is...
New study reports no delay in EVT treatment during COVID-19 period
A study recently published in the BMJ reports no observed delay in the treatment of patients with intracranial occlusion with endovascular thrombectomy (EVT) during the...
Danish Study reports fewer older people suffering strokes
A study published in the online issue of Neurology has found that people aged 70 and older are having fewer strokes and are also...
First patient treated in eShunt clinical trial
CereVasc has announced the treatment of the first patient in a study of its eShunt System, an investigational device intended to treat communicating hydrocephalus...
ShiraTronics receives FDA breakthrough device designation for chronic migraine therapy
ShiraTronics has announced that it has been granted a breakthrough device designation by the Center of Devices and Radiological Health (CDRH) of the US...
Azurity Pharmaceuticals announces three new neurology products
Azurity Pharmaceuticals has announced the purchase of Eton Pharmaceuticals' neurology portfolio.
These products include lamotrigine (ET-105), zonisamide (ET-104), and topiramate (ET-101). According to Azurity, these...
Canadian TIA score identifies risk in mini-stroke patients of subsequent stroke,...
A new study published in the British Medical Journal (BMJ), has concluded that the Canadian transient ischaemic attack (TIA) score identifies the risk of...
Vesalio receives peripheral FDA clearance and CE mark
Vesalio has announced in a company press release that it has received 510(k) clearance from the US Food and Drug Administration (FDA) and its...
Vercise Genus DBS system received FDA approval
Boston Scientific has announced that it has received US Food and Drug Administration (FDA) approval for its fourth-generation Vercise Genus deep brain stimulation (DBS) system.
According to a company press release, the...
Biogen announces FDA approval of Plegridy intramuscular administration for multiple sclerosis
Biogen has announced that the US Food and Drug Administration (FDA) has approved a new intramuscular (IM) injection route of administration for Plegridy (peginterferon...
Biomodex announce partnership to develop Evias Plus
Biomodex has announced its partnership with two of the top medical centres in France and a health system in the USA to develop Evias...
Understanding the neural circuits underlying movement control to enhance stroke recovery
Stuart Baker is a professor of Movement Neuroscience at Newcastle University, Newcastle, England. He previously presented virtually on this topic at the UK Stroke...
Medtronic announces release of its new radial artery access portfolio
Medtronic today announced expansion of the limited site release of its recently acquired radial artery access portfolio from privately-held Rist Neurovascular, following first-in-patient procedure....
Longeviti announces FDA clearance of its ClearFit implant
Longeviti Neuro Solutions has announced the 510(k) clearance by the US Food and Drug Administration (FDA) of its ClearFit cranial implant, which it claims...
Closed-loop neuromodulation could restore memory after traumatic brain injury
A new randomised controlled trial presented at the North American Neuromodulation Society (NANS) virtual meeting (15–16 January), presented by Robert E Gross (Emory University...
Future stroke rehabilitation could include robotic therapy
At the North American Neuromodulation Society (NANS) virtual meeting (15–16 January), Dylan J Edwards, director of the Moss Rehabilitation Research Institute and director of...
New study reports directional DBS provides superior results to omnidirectional DBS...
Results from a multi-centre, prospective, blinded, crossover study, presented at the North American Neuromodulation Society (NANS) virtual meeting (15–16 January) by Jan Vesper (Heinrich-Heine...
BioArctic receives European patent for antibodies targeting Alzheimer’s disease
BioArctic AB has announced that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for...
New study shows improvement in opioid withdrawal symptoms through non-invasive neuromodulation
A late-breaking abstract presented at the North American Neuromodulation Society (NANS) 2021 virtual meeting (January 15–16) has shown that non-invasive neuromodulation may present a...
CATHI launches portable endovascular simulator system
CATHI has launched a campaign promoting CATHIS Smart, its portable system, to medical technology and pharmaceutical companies. CATHIS Smart displays all types of endovascular...
Seneca Biopharma announces phase II clinical study for treatment of ischaemic...
Seneca Biopharma has announced its preliminary top-line results of the placebo-controlled phase II stroke study that was conducted in Beijing, China.
According to a company...
New study supports Anaconda Biomed’s ANA catheter system for ischaemic stroke
New single-centre clinical study data published in the Journal of Neuroradiology claims to support the Anaconda Neurovascular Access (ANA) catheter system for the treatment...
VeraSci partners with ActiGraph for wearables clinical trial monitoring Alzheimer’s decline
VeraSci has announced a partnership with ActiGraph, to expand the use of wearables in clinical trials.
According to a company press release, VeraSci's Innovation Lab...
Neuro News Issue 40 – US Edition
Highlights:
Coverage of the joint European Stroke Organisation and the World Stroke Organisation (WSO-ESO 2020) conference (7–9 November 2020), including how artificial intelligence can...
Neuro News Issue 40 – EU Edition
Highlights:
Coverage of the joint European Stroke Organisation and the World Stroke Organisation (WSO-ESO 2020) conference (7–9 November 2020), including how artificial intelligence can...
UCB announces launch of Nile AI
UCB has announced the launch of Nile AI, a separate company, with the aim of developing an epilepsy care management platform. According to UCB,...
Medtronic launches aDBS trial in Parkinson’s disease patients
Medtronic has announced the first enrolment in its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson’s...
INSIST in silico project: The future of randomised controlled trials
The in silico trials for treatment of acute ischaemic stroke (INSIST) consortium began in 2017 and presented its concepts and first results at the...
The relevance of a strong healthcare system for acute stroke care...
Blanca Fuentes, María Alonso de Leciñana, and Exuperio Díez Tejedor write about the challenges faced in the management of stroke care throughout the pandemic,...
Global drive to increase awareness, action and access to mechanical thrombectomy...
Mission Thrombectomy 2020+ (MT2020+), a global campaign of SVIN (Society of Vascular and Interventional Neurology), recently published Mechanical Thrombectomy for Acute Stroke. Building Thrombectomy...
ClearMind Biomedical receives FDA clearance for neuroendoscope
ClearMind Biomedical has announced 510(K) US Food and Drug Administration (FDA) clearance for its Axonpen System, which is used for the illumination and visualisation...
Vercise DBS receives breakthrough device designation from FDA
Functional Neuromodulation has announced that the Vercise deep brain stimulation (DBS) device, developed and manufactured by Boston Scientific, has received breakthrough device designation from...
BioSerenity receives FDA clearance for EEG wearable device system
BioSerenity has announced that its electroencephalography (EEG) wearable device system has received 510(k) clearance from the US Food and Drug Administration (FDA). This clearance...
Alnylam reports positive results from HELIOS-A phase III study of Vutrisiran...
Alnylam Pharmaceuticals has announced that the HELIOS-A phase III study of Vutrisiran, an investigational RNA interference (RNAi) therapeutic in development for the treatment of...
Study finds people in rural areas less likely to receive specialty...
According to a press release by the American Academy of Neurology (AAN), a new study has found that while the prevalence of neurologic conditions...
First-pass effect lowers costs in treatment of acute ischaemic stroke, study...
A study published in the British Medical Journal (BMJ) has found that first-pass effect (FPE), restoring complete or near complete reperfusion (modified Thrombolysis in...
First robotic-assisted intracranial implant of Cerus Endovascular contour intrasaccular device
Cerus Endovascular has announced in a press release the first-ever robotic-assisted intracranial implant of its Contour intrasaccular device.
The procedure was completed by Nitin Dange...
Rapid Medical receives FDA clearance for steerable neurovascular guidewire
Rapid Medical has announced its Drivewire novel guidewire with a steerable distal top, has received US Food and Drug Administration (FDA) clearance. According to...
Cognoptix makes new appointments
Cognoptix has announced new appointments to their senior management team. Carl Sadowsky (Nova SE University, West Palm Beach, USA) has been appointed as chief...
Stroke increases risk of death of COVID-19, according to new study
A study published in Neurology claims that people hospitalised with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying...
Emulate unveils brain-chip
Emulate has unveiled a brain-chip aimed at enhancing neuroinflammatory disease research and drug discovery. According to a press release by emulate, the comprehensive neurovascular...
Lancet study reports positive phase III clinical trial results for rimegepant...
Biohaven Pharmaceutical Holding Company has announced that The Lancet has published the company's positive results from a phase III clinical trial of rimegepant for...
Penumbra recalls JET 7 catheters with Xtra Flex technology
The US Food and Drug Administration (FDA) announced the urgent voluntary recall of Penumbra’s JET 7 catheters with Xtra Flex technology (JET 7 Xtra...
Meta-analysis of acute migraine treatment devices finds evidence in support of...
According to a press release produced by Theranica, a peer-reviewed study published in The Journal of Headache and Pain, has concluded that remote electrical...
Neuroscientist offers personal account of the harmful effects of tDCS and...
Sandra Boccard-Binet is a research scientist at the University of Oxford, Oxford, UK. Her research focuses on deep brain stimulation. Here she writes about...
New research suggests paramedics could use FaceTime to improve stroke assessment
New research presented at the UK Stroke Forum (7–9 December, virtual) suggests that paramedics could use FaceTime to improve their assessment of someone experiencing...
Neurotrope completes formation of new company Synaptogenix
Neurotrope announced the completion of an independent spin-off of neurotrope bioscience, which has now been renamed as Synaptogenix, trading under the symbol SNPX.
Daniel Alkon,...
Diadem presents clinical data at Alzheimer’s disease international conference
Diadem presented its clinical Data and commercialisation plans for its AlzoSure prognostic biomarker test, a blood-based test for the early prediction of Alzheimer's disease...
IRRAS expands IRRAflow device to Latin America
IRRAS AB has announced it has reached an exclusive distribution agreement for their IRRAflow device, with Anade SA, a well-established distributor of leading neurosurgical...
Testing Artificial Intelligence software used to identify stroke features
Grant Mair, the Stroke Association’s Edith Murphy Foundation Senior Clinical Lecturer, University of Edinburgh, and honorary consultant neuroradiologist, NHS Lothian, Scotland. At the ESC-WSO...
Evasc announces CE mark for its remodelling system
Evasc has announced that the new Electric eCLIPs Bifurcation Remodeling System (eB) has been granted a CE Mark.
The eB builds on eCLIPs highly effective...
Research shows better cognition with non-invasive vagal nerve stimulation
In a study published this week in Neuromodulation: Technology at the Neutral Interface, authors report that they have initial evidence that non-invasive vagal nerve...
Axonics announces publication of faecal incontinence neuromodulation implant study
Axonics, California, USA, has announced that a study, named ARTISAN, looking at its implantable sacral neuromodulation (SNM) devices for the treatment of urinary and...
NICO.LAB receives FDA clearance for AI stroke care solution
NICO.LAB has received clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI) powered solution in stroke care, StrokeViewer LVO.
According...
Stroke risk disparities in black and white patients related to cardiac...
In a new study published in the online issue of Neurology, researchers claim to have found difference in the left atrium in the hearts...
Avicenna.AI Stroke detection tool approved for Medicare NTAP
Aviceanna.AI has announced that its medical imaging artificial intelligence (AI) tool, CINA Head, has qualified for the new technology add-on payment (NTAP) recently approved...
Alison Twiner appointed as Chair on Heart & Stroke National Board...
Heart & Stroke has announced that Alison Twiner has been appointed as a chair on its National Board of Directors. Twiner has served of...
Wallaby Medical closes US$45 million Series C funding
Wallaby Medical, a medical device company focused on stroke treatment, has announced the closing of a US$45 million Series C funding.
This round of funding...
Rapid Medical receives CE mark for remodelling mesh device
Rapid Medical has announced that its adjustable remodelling mesh device, called Comaneci, has received CE mark approval. Comaneci is intended to treat cerebral vasospasm...
Boston Scientific launches Vercise Genus DBS on European Market
Boston Scientific has announced that its Vercise Genus deep brain stimulation (DBS) device has received a CE Mark. This is a fourth generation device...
Implantable brain-computer interface allows severe paralysis patients to complete daily tasks
The Stentrode brain-computer interface (BCI) has successfully been demonstrated by researchers to help patients with severe paralysis complete tasks such as texting, emailing, shopping...
FDA sends out Class 1 recall for stryker’s Trevo XP ProVue...
The US Food and Drug Administration (FDA) has sent out a class one recall, the most serious level of recall, for Styrker’s Trevo XP...
New study finds diabetes and hypertension may increase risk of COVID-19...
A new study presented at the Radiological Society of North America (RSNA) annual meeting shows that COVID-19 patients with the pre-existing conditions hypertension and...
Fycompa receives approval from European Commission for use in children with...
Fycompa or perampanel, an anti-epileptic agent, has now been approved by the European Commission (EC) for use in children, according to a press release...
RapidAI experiences nearly 300% growth
RapidAI, a neuroimaging stroke software platform which uses artificial intelligence (AI), has announced growth of nearly 300%. This has been attributed by RapidAI in...
Abbott announces the US launch of their IonicRF device
Abbott has announced that their IonicRF, a minimally invasive radiofrequency ablation device, is now being launched in the USA. This is after the IonicRF...
ESO-WSO: AI can be used for automatic segmentation of stroke infract...
A study presented by Kelvin Wong (Houston Methodist, Houston, US) at the European Stroke Organisation and the World Stroke Organization joint virtual conference (ESO-WSO...
Avicenna AI announces partnership with Canon Medical Systems
Avicenna AI has announced they will partner with Canon Medical Systems to deliver a fully integrated stroke detection artificial intelligence (AI) solution.
Avicenna AI specialises...
Cost of stroke care in Europe could increase to €86 billion by 2040
A new report from the Stroke Alliance for Europe (SAFE), shows that if countries continue to fail to invest in stroke prevention, treatments and...
Brilinta with aspirin reduced disabling stroke or death in patients with...
Results from a prespecified exploratory analysis of the positive THALES phase III trial have shown that for patients with acute ischaemic stroke or transient...
ESO-WSO 2020: No reason to withhold EVT for older patients with...
A study presented by Johanna Ospel (University of Calgary, Calgary, Canada) at the European Stroke Organisation and the World Stroke Organization joint virtual conference...
New Phagenyx study shows significant benefits for patients with neurogenic dysphagia
The largest real world study of Phagenyx, a form of Pharyngeal Electrical Stimulation (PES), was published in the journal EClinicalMedicine – The Lancet, and...
New Heart & Stroke survey finds that stroke and heart disease...
A new survey from the Heart & Stroke Foundation of Canada, conducted on over 1200 people with conditions and their caregivers, found that approximately...
Stryker’s Mark Paul talks COVID-19 and developments in the neurovascular field
The pandemic has affected the lives of everyone across the world, but especially those in the medical field. Physician’s daily practices have changed, but...
FDA grants Breakthrough Device Designation for Salvia BioElectronics migraine treatment
Salvia BioElectronics, Eindhoven, Netherlands, have received a Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its implantable neurostimulation system for...
Alzinova AB announce clinical trials for Alzheimer’s vaccine candidate
Alzinova AB, Stockholm, Sweden, have announced its upcoming clinical study for Alzheimer’s disease vaccine candidate ALZ-101, which will take place in the second quarter...
Nurami Medical Raises an estimated $6 Million for series B Funding
Nurami Medical, a medical nanofiber technology company, has raised up to $6 million in series B funding to finance ongoing clinical trials for ArtiFascia....
LINNC Paris event cancelled
The organisers of the Live Interventional Neuroradiology, Neurology & Neurosurgery Course (LINNC) Paris 2020 event have announced its cancellation due to the French governments’...
Medtronic receive FDA approval for NIM Vital
Medtronic has received their US Food and Drug (FDA) 530(k) clearance of their NIM Vital nerve monitoring system. The NIM system helps physicians identify,...
SVIN issues white paper on mechanical thrombectomy in acute strokes
The society of Vascular and International Neurology (SVIN) has issued a white paper as part of their global campaign, Mission Thrombectomy 2020.
The paper,...
Jens Fiehler
Virtual education offers unparalleled, and relatively inexpensive opportunities, but the joy of interacting in-person with colleagues and, frankly, appreciating a fine vintage after sessions,...
Stroke Association reveals that 29% of stroke survivors during the pandemic...
Almost one in three of those who suffered a stroke during the pandemic delayed seeking medical attention due to COVID-19 fears. The Stroke Association...
Study shows that p-tau T217 has better diagnostic accuracy for detecting...
A recent study, published by Neurology, found that p-tau T217 has better diagnostic accuracy for detecting Alzheimer’s disease than p-tau T181. Jozef Hanes, AXON...
Keck Medicine to enrol individuals in phase 3 clinical trial to...
Keck Medicine, of the University of Southern California, Los Angles, USA, is enrolling individuals in an international phase 3 clinical trial to study deep...
Neuromod closes €10.5 million financing for Tinnitus treatment device
Neuromod has secured a series B €10.5 million financing for its Lenire tinnitus treatment device. This funding follows the publication of the company’s first...
